Sort
40,608 grants matching “prostate cancer”
Multilevel Interventions to Increase Adherence to Lung Cancer Screening
$621,529Karen J Wernli · Kaiser Foundation Research Institute · R01 · FY2025 · CA
Advanced diffusion MRI for evaluating early response to radiation treatment in cervical cancer
$621,428Rebecca Ann Rakow-Penner · University Of California, San Diego · R37 · FY2022 · CA
Molecular imaging of novel PARP inhibitor nanomedicine delivery
$621,383Henry F. Vanbrocklin · University Of California, San Francisco · R01 · FY2025 · CA
Dynamic PET-DECT for Proton Treatment Verification and Response Assessment
$621,301Xuping Zhu · Massachusetts General Hospital · R01 · FY2016 · EB
Intimacy-Enhancing Couples' Intervention for Localized Prostate Cancer
$621,240Sharon L Manne · Univ Of Med/Dent Nj-R W Johnson Med Sch · R01 · FY2012 · CA
Environmental chemicals impair epigenetic suppression of the endogenous retrovirus HML-2 in human primordial germ cells, predisposing the next generation to malignancies through HML-2 reactivation
$620,940Toshihiro Shioda · Massachusetts General Hospital · R01 · FY2024 · ES
Biomarker Approaches to Individualizing Systemic Therapy for High Risk Prostate Cancer
$620,906Felix Yi-Chung Feng · University Of California, San Francisco · R01 · FY2022 · CA
Methods and Tools for Integrating Pathomics Data into Cancer Registries
$620,871Joel H Saltz · State University New York Stony Brook · UH3 · FY2021 · CA
Development of Spectral Phase Contrast Micro-CT
$620,830Mini Das · University Of Houston · R01 · FY2023 · EB
Investigating CREB5-driven mechanisms of immune therapy resistance
$620,820Robert Thomas Manguso · Massachusetts General Hospital · R01 · FY2025 · CA
Multiplexed Nanosensing for DNA and Proteins
$620,767Richard James Cote · University Of Miami School Of Medicine · R01 · FY2009 · EB
IDENTIFYING AND TARGETING MDV3100 RESISTANCE MECHANISMS IN PROSTATE CANCER
$620,724Oregon Health & Science University · · FY2013 · Department of the Army
Genetic Epidemiology of Telomere Maintenance and Cancer Etiology
$620,698Sharon A. Savage · Division Of Cancer Epidemiology And Genetics · ZIA · FY2024 · CA
ENTERED ON 11/14/2019-MULTIFUNCTIONAL PSCA ANTIBODY FRAGMENTS FOR PET AND OPTICAL PROSTATE CANCER IMAGING...ENTERED 999 FOR NUMBER OF PROPOSALS...SIGNED 9/24/2015, EFFECTIVE 9/30/2015, FAADC ON 11/14/2019
$620,628University Of California, Los Angeles · · FY2015 · Department of the Army
Restore: Improving Sexual Outcomes of Gay and Bisexual Prostate Cancer Survivors
$620,544B. R. Simon Rosser · University Of Minnesota · R01 · FY2017 · CA
A blood test to identify prostate cancer patients at risk for visceral metastasis
$620,500Edwin Melencio Posadas · Cedars-Sinai Medical Center · R01 · FY2017 · CA
Novel Hyperpolarized MR Markers of Advanced Prostate Cancer Therapy
$620,489John Kurhanewicz · University Of California, San Francisco · R01 · FY2016 · CA
Biological Studies
$620,426Brian E Henderson · University Of Southern California · U19 · FY2010 · CA
GENOME-WIDE ASSOCIATION STUDY TO IDENTIFY SNPS AND CNPS ASSOCIATED WITH DEVELOPMENT OF RADIATION INJURY IN PROSTATE CANCER PATIENTS TREATED WITH RADI
$620,310Icahn School Of Medicine At Mount Sinai · · FY2008 · Department of the Army
Accurate MR-based PET Attenuation Correction for Quantitative Clinical Trials
$620,305Raymond F Muzic · Case Western Reserve University · R01 · FY2015 · CA
Caregiver Coping Skills training for Lung Cancer
$620,301Duke University · R01 · FY2002 · CA
Genetics Variants in the Genome Predisposing to Aggressive PCa
$620,255William B Isaacs · Johns Hopkins University · R01 · FY2010 · CA
CAREER: Modulating Local Tumor Hypoxia using Cryogel Scaffolds to Regulate Dendritic Cell Function and Activity
$620,046Sidi A Bencherif · Northeastern University · · FY2019 · MPS
SAN ANTONIO CENTER OF BIOMARKERS OF RISK FOR PROSTATE CA
$620,026University Of Texas Hlth Sci Ctr San Ant · U01 · FY2004 · CA
Enhancing Epigenetic Analysis Of Rare Cells With Multi-Phase Microfluidics
$620,020David J Beebe · University Of Wisconsin-Madison · R01 · FY2022 · CA